Abstract
Gaucher's disease is the most common inherited lysosomal storage disorder, displaying hepato-splenomegaly, thrombocytopenia, anaemia and bone pain as characteristic features. Substitution therapy with a modified enzyme alglucerase has revolutionized the treatment and prognosis of Gaucher's disease. The first Danish patients treated with alglucerase are reported.
| Bidragets oversatte titel | Gaucher disease type 1--therapeutic results of enzyme substitution |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 160 |
| Udgave nummer | 26 |
| Sider (fra-til) | 3929-30 |
| Antal sider | 2 |
| ISSN | 0041-5782 |
| Status | Udgivet - 22 jun. 1998 |
Emneord
- Adolescent
- Adult
- Female
- Gaucher Disease/diagnosis
- Glucosylceramidase/therapeutic use
- Humans
- Prognosis